In spite of getting produced for under $five per month, copyright carries a retail selling price which is tough to justify. The significant hole among manufacturing costs and pricing raises significant questions about the pharmaceutical sector's pricing strategies.California biotech behemoth Amgen ditched options for an experimental weight loss cap